Golden has been acquired by ComplyAdvantage.Read about it here ⟶

RareCyte

RareCyte is a Seattle-based company focused on developing tools and technologies for oncology, immuno-oncology, maternal-fetal health, and cell and gene therapy companies.

Overview Structured Data Issues Contributors Activity

rarecyte.com

Is a

Organization

Company

Company attributes

Industry

Location

CEO

Pitchbook URL

pitchbook.com/profiles.../55058-14

Email Address

info@rarecyte.com

support@rarecyte.com

Phone Number

+12064559092

+18557273298

Full Address

2601 Fourth Ave, #500 Seattle, WA 98121

Investors

F-Prime Capital Partners

Fax Number

206-455-9089

Total Funding Amount (USD)

46,000,000

Latest Funding Round Date

September 14, 2021

Board of Directors

CFO

Latest Funding Type

Other attributes

Latest Funding Round Amount (USD)

24,000,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like RareCyte

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API